Nature has issued an author correction for the paper De novo design of quasisymmetric two-component protein cages, published June 9, 2026. The correction, carrying DOI 10.1038/s41586-026-10763-6, updates the original research article in the journal. No further details on the specific changes have been released beyond the standard correction notice.
What the correction covers
The correction applies to the original research paper, which focused on designing protein cages with quasisymmetric two-component structures. Nature's process for author corrections typically addresses errors or omissions that do not affect the overall conclusions of the work. The updated version of the paper is now available through the journal's website.
📊 Market Data Snapshot
Market context – a quiet day for crypto
The correction comes on a day when crypto markets are gripped by extreme fear — the Fear & Greed index sits at 10, its lowest possible reading. Bitcoin is consolidating below $63,500, and altcoin dominance remains low. In this environment, a scientific correction in a non-crypto field doesn't move prices. But for researchers and biotech investors tracking molecular computing and bio-blockchain convergence, the refinement signals ongoing progress in a niche that could eventually intersect with crypto infrastructure.
What comes next
The corrected paper is now live on Nature's site. No word on whether the authors plan further amendments or if the work will influence any patent filings. For now, the story is a quiet editorial fix — not a catalyst, but a reminder that foundational science keeps advancing even when markets aren't watching.
